Scientists, UC San Francisco develop COVID-19 antiviral nasal spray, inhaler

Scientists and UC San Francisco announced an inhalable protection against COVID-19 with the goal of being produced into an affordable, over-the-counter antiviral medication in the coming months. UCSF is working to start human trials on what they have called “AeroNabs.” Get the full story in the video above.

Scientists, UC San Francisco develop COVID-19  antiviral nasal spray, inhaler

Scientists, UC San Francisco develop COVID-19  antiviral nasal spray, inhalerScientists and UC San Francisco announced an inhalable protection against COVID-19 with the goal of being produced into an affordable, over-the-counter antiviral medication in the coming months. UCSF is working to start human trials on what they have called “AeroNabs.” Get the full story in the video above.